These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16831885)

  • 1. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability.
    Galvez BG; Sampaolesi M; Brunelli S; Covarello D; Gavina M; Rossi B; Constantin G; Torrente Y; Cossu G
    J Cell Biol; 2006 Jul; 174(2):231-43. PubMed ID: 16831885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts.
    Bernal A; San Martín N; Fernández M; Covarello D; Molla F; Soldo A; Latini R; Cossu G; Gálvez BG
    Cell Death Differ; 2012 Feb; 19(2):345-55. PubMed ID: 21869829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy.
    Sciorati C; Galvez BG; Brunelli S; Tagliafico E; Ferrari S; Cossu G; Clementi E
    J Cell Sci; 2006 Dec; 119(Pt 24):5114-23. PubMed ID: 17158915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts.
    Sampaolesi M; Torrente Y; Innocenzi A; Tonlorenzi R; D'Antona G; Pellegrino MA; Barresi R; Bresolin N; De Angelis MG; Campbell KP; Bottinelli R; Cossu G
    Science; 2003 Jul; 301(5632):487-92. PubMed ID: 12855815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice.
    Guttinger M; Tafi E; Battaglia M; Coletta M; Cossu G
    Exp Cell Res; 2006 Nov; 312(19):3872-9. PubMed ID: 16982052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo.
    Gargioli C; Turturici G; Barreca MM; Spinello W; Fuoco C; Testa S; Feo S; Cannata SM; Cossu G; Sconzo G; Geraci F
    Cell Death Dis; 2018 Jan; 9(1):1. PubMed ID: 29298988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
    Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
    Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity.
    Messina G; Sirabella D; Monteverde S; Galvez BG; Tonlorenzi R; Schnapp E; De Angelis L; Brunelli S; Relaix F; Buckingham M; Cossu G
    Stem Cells; 2009 Jan; 27(1):157-64. PubMed ID: 18845762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy.
    Millay DP; Sargent MA; Osinska H; Baines CP; Barton ER; Vuagniaux G; Sweeney HL; Robbins J; Molkentin JD
    Nat Med; 2008 Apr; 14(4):442-7. PubMed ID: 18345011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Globular adiponectin as a complete mesoangioblast regulator: role in proliferation, survival, motility, and skeletal muscle differentiation.
    Fiaschi T; Tedesco FS; Giannoni E; Diaz-Manera J; Parri M; Cossu G; Chiarugi P
    Mol Biol Cell; 2010 Mar; 21(6):848-59. PubMed ID: 20089845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necdin enhances muscle reconstitution of dystrophic muscle by vessel-associated progenitors, by promoting cell survival and myogenic differentiation.
    Pessina P; Conti V; Tonlorenzi R; Touvier T; Meneveri R; Cossu G; Brunelli S
    Cell Death Differ; 2012 May; 19(5):827-38. PubMed ID: 22095287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
    Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
    J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.
    De Bari C; Dell'Accio F; Vandenabeele F; Vermeesch JR; Raymackers JM; Luyten FP
    J Cell Biol; 2003 Mar; 160(6):909-18. PubMed ID: 12629053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice.
    Blades MC; Ingegnoli F; Wheller SK; Manzo A; Wahid S; Panayi GS; Perretti M; Pitzalis C
    Arthritis Rheum; 2002 Mar; 46(3):824-36. PubMed ID: 11920421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis.
    Contreras O; Rebolledo DL; Oyarzún JE; Olguín HC; Brandan E
    Cell Tissue Res; 2016 Jun; 364(3):647-660. PubMed ID: 26742767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth Factor Screening in Dystrophic Muscles Reveals PDGFB/PDGFRB-Mediated Migration of Interstitial Stem Cells.
    Camps J; Grosemans H; Gijsbers R; Maes C; Sampaolesi M
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
    Gawlik KI; Holmberg J; Durbeej M
    Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice.
    Sasaoka T; Imamura M; Araishi K; Noguchi S; Mizuno Y; Takagoshi N; Hama H; Wakabayashi-Takai E; Yoshimoto-Matsuda Y; Nonaka I; Kaneko K; Yoshida M; Ozawa E
    Neuromuscul Disord; 2003 Mar; 13(3):193-206. PubMed ID: 12609501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.
    Torrente Y; Camirand G; Pisati F; Belicchi M; Rossi B; Colombo F; El Fahime M; Caron NJ; Issekutz AC; Constantin G; Tremblay JP; Bresolin N
    J Cell Biol; 2003 Aug; 162(3):511-20. PubMed ID: 12885758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.